Singh Shawn 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2025-06-30$1.70/sh+7,541$12,820→ 18,028 total
Holdings
- 20,875(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).